67. READER WITH POST POLIO SYNDROME

"I have Post Polio (PPS) which from reading your Newsletters, is very closely related to FMS. We are blessed because Dr. Richard Bruno has done extensive research into autopsie reports of polio victims since the early 1900's. In his book Understanding and treating "Post-Polio Syndrome" and Chronic Fatigue The Polio Paradox  , he reveals that the spots on the brain cannot be seen by machines until they are large enough and by then we have severe fatigue syndrome.

We have developing brain fog also. Due to an extensive injection of anesthesia over the last year, my concentration was fading fast. I changed from an optimistic attitude to a pessimistic attitude. Great concern drove me to the internet. The permanent workable positive results:

1. Protein / Carbohydrate Ratio diet of 3:4 (lost 10 lbs and blood pressure returned to normal)

2. Flaxseeds (Optimistic attitude & concentration returned to what it was before the anesthesia damage to the brain and nervous system). Flaxseeds are one of the highest foods in lignans and Omega 3 oils.

3. Fresh raw coconut (Stablized my weight on a regular diet with very little exercise due to my severe neuron damage which causes severe fatigue after short periods of walking or standing) Also, balanced my thyroid hormones to function more normally. Normal appetite returned.

4. Cilantro Chelation - a handful of cilantro leaves per day for 2 to 3 weeks (Rid my body of mercury and heavy metal poisoning. Viruses and bacteria in the body are freed by the loss of the mercury so 2 1/2 tablespoons of brown flaxseeds per day is needed to delete these viruses and bacteria.) Grind the flaxseeds with a coffee grinder or blender using an ice blade. Mix with 5 tablespoons of water or sprinkle on cold cereal, not hot) Excessive heat, oxygen, and light damage flaxseeds. Eat within 15 minutes after grinding to receive the full benefit. Keep flaxseeds in the refrigerator or freezer.

4. B.E.S.T (BioEnergetic Synchronization Technique) to keep the best possible electrical flow throughout my body.  This also corrected my shoulders and neck slump after 2 weeks of 3 times a week treatments. As my nerve flow weakens, my muscles shorten and become weaker and painful with the shortening pull on them. This treatement begins to reverse that action. Then I return every 3 to 4 weeks for a tuneup because my nerve flow gradually drops with muscle use over a period of a month.  I prefer going to a 'Master" B.E.S.T level of Doctor of Chiropractic who is in good health because if the doctor's nervous system is strong then my nervous system is helped more. http://www.morter.com/practitioner.php "

==================================================

1. Major Drug Recall. N.J. drug maker, Able Laboratories, suspends manufacturing
operations and recalls all drugs.

New Jersey company Able Laboratories suspended manufacturing
operations and voluntary recalled all of their drug products because of the
FDA's serious concerns that they were not produced according to quality
assurance standards. It is important to note that this recall only
applies to the drugs produced by Able Laboratories - and not to the same
drugs produced by other manufacturers. For more information, please see FDA
press release. Recalled drugs include: Acetaminophen & codeine,
Hydrocodone bitartrate apap, Indomethacin, Naproxen Sodium,
Propoxyphene naps/apap (generic name and under the Ivax label), and Tramadol HCL
(under the Ivax label).

Download a sample patient notice at http://www.spine.org/Forms/Able_laboratories_sample.pdf

2.  Duragesic and the generic product WARNING

FDA issued a public health advisory to alert health care
professionals,
patients and their caregivers of reports of death and other serious
side effects from overdoses of fentanyl in patients using fentanyl
transdermal (skin) patches for pain control. Deaths and overdoses
have occurred in patients using both the brand name product Duragesic and
the generic product. Some patients and health care providers may not be
fully aware of the dangers of this very strong narcotic painkiller. The
directions for using the fentanyl skin patch must be followed exactly
to prevent death or other serious side effects from overdosing with
fentanyl.

Read the MedWatch safety summary, including links to the Public
Health Advisory, Healthcare Professional and Patient Information Sheets, and
the Drug Information Page at: http://www.fda.gov/medwatch/SAFETY/2005/safety05.htm#Fentanyl

3. Pregabalin, Report Describes Potential Problem

A report in the July Annals of Neurology describes a serious adverse
event experienced by a participant in a clinical trial that may raise
a new caution about the use of antiepileptic drugs for conditions other
than epilepsy. An elderly women enrolled in a clinical trial of
pregabalin, a new drug for the treatment of pain and seizures,
abruptly discontinued the medication and then developed neurological symptoms
including headache, confusion and hallucinations. The study's authors from
Massachusetts General Hospital (MGH) suggest that all patients
stopping antiepileptic drugs (AEDs) should do so gradually to avoid
complications of withdrawal.

Full Story: http://www.sciencedaily.com/releases/2005/07/050711015101.htm#

4. Antidepressant Medications and the risk of suicidality

FDA notified healthcare professionals about the availability of
updated Healthcare Professional and Patient Information Sheets for
antidepressant medications that were the subject of a June 30, 2005
Public Health Advisory issued about the risk of suicidality (suicidal thinking or
behaviour) in adults being treated with antidepressant medications.

Read the complete MedWatch 2005 Safety summary, including links to
the original June 30 PHA and the updated information sheets, at:
http://www.fda.gov/medwatch/SAFETY/2005/safety05.htm#antidepressant

5. Suicidality in Pediatric and Adult Patients on/off Paxil

FDA has concluded that suicidal thinking or behaviour may increase in
pediatric patients treated with any type of antidepressant,
especially early in treatment. Increases in suicidal thinking or behaviour due
to drug can be expected in about 1 out of 50 treated pediatric patients.
Note that, although paroxetine is prescribed for pediatric patients,
it is not approved by FDA for use in pediatric patients.

Full Story: http://www.fda.gov/cder/drug/InfoSheets/HCP/paroxetineHCP.htm